PMID- 37189364 OWN - NLM STAT- MEDLINE DCOM- 20230517 LR - 20230530 IS - 2218-273X (Electronic) IS - 2218-273X (Linking) VI - 13 IP - 4 DP - 2023 Mar 29 TI - Correlation between Blood Lipid Level and Osteoporosis in Older Adults with Type 2 Diabetes Mellitus-A Retrospective Study Based on Inpatients in Beijing, China. LID - 10.3390/biom13040616 [doi] LID - 616 AB - OBJECTIVE: to analyze the association between blood lipid metabolism and osteoporosis (OP) in older adults with type 2 diabetes mellitus (T2DM). METHODS: a total of 1158 older patients with T2DM treated by the Department of Endocrinology, Peking University International Hospital, were retrospectively analyzed, including 541 postmenopausal women and 617 men. RESULTS: (1) Levels of low-density lipoprotein cholesterol (LDL-C) were significantly higher in the OP group, while levels of high-density lipoprotein cholesterol (HDL-C) were higher in the non-osteoporotic group (both p < 0.05). (2) Age, parathyroid hormone (PTH), total cholesterol (TC) and LDL-C were negatively linked to the patients' bone mineral density (BMD) (all p < 0.05), while the body mass index (BMI), uric acid (UA) level, HDL-C level and glomerular filtration rate (eGFR) were positively related to their BMD (all p < 0.05). (3) In postmenopausal women, after adjustment for other indexes, raised LDL-C is an independent risk factor for OP (OR = 3.38, 95% CI 1.64, 6.98, p < 0.05) while raised HDL-C is protective (OR = 0.49, 95% CI 0.24, 0.96, p < 0.05). However, raised HDL-C was protective against OP (OR = 0.07, 95% CI 0.01, 0.53, p < 0.05). CONCLUSION: In older T2DM patients, the effect of blood lipid levels is related to sex. Our study conducted a detailed sex stratification. In addition to seeing the traditional risk factors of OP, such as age, sex, and BMI, we comprehensively analyzed the correlation between the blood glucose level, complications, and blood lipids with OP. HDL-C is a protective factor for OP in both men and women, while LDL-C independently predicts OP in postmenopausal women. FAU - Zhao, Xin AU - Zhao X AD - Department of Endocrinology, Peking University International Hospital, Beijing 100001, China. FAU - Sun, Jianbin AU - Sun J AD - Department of Endocrinology, Peking University International Hospital, Beijing 100001, China. FAU - Xin, Sixu AU - Xin S AD - Department of Endocrinology, Peking University International Hospital, Beijing 100001, China. FAU - Zhang, Xiaomei AU - Zhang X AD - Department of Endocrinology, Peking University International Hospital, Beijing 100001, China. LA - eng PT - Journal Article DEP - 20230329 PL - Switzerland TA - Biomolecules JT - Biomolecules JID - 101596414 RN - 0 (Cholesterol, LDL) RN - 0 (Lipids) RN - 0 (Cholesterol, HDL) SB - IM MH - Male MH - Humans MH - Female MH - Aged MH - Retrospective Studies MH - *Diabetes Mellitus, Type 2/complications MH - Cholesterol, LDL MH - Inpatients MH - Beijing/epidemiology MH - *Osteoporosis MH - Lipids MH - Cholesterol, HDL PMC - PMC10136067 OTO - NOTNLM OT - bone mineral density OT - high-density lipoprotein cholesterol OT - low-density lipoprotein cholesterol OT - osteoporosis OT - type 2 diabetes mellitus COIS- The authors declare no conflict of interest. EDAT- 2023/05/16 06:42 MHDA- 2023/05/17 06:42 PMCR- 2023/03/29 CRDT- 2023/05/16 01:09 PHST- 2022/11/29 00:00 [received] PHST- 2023/02/12 00:00 [revised] PHST- 2023/03/23 00:00 [accepted] PHST- 2023/05/17 06:42 [medline] PHST- 2023/05/16 06:42 [pubmed] PHST- 2023/05/16 01:09 [entrez] PHST- 2023/03/29 00:00 [pmc-release] AID - biom13040616 [pii] AID - biomolecules-13-00616 [pii] AID - 10.3390/biom13040616 [doi] PST - epublish SO - Biomolecules. 2023 Mar 29;13(4):616. doi: 10.3390/biom13040616.